SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo

Cancer Letters (2014) - Comments
doi: 10.1016/j.canlet.2014.05.012 issn: 0304-3835 pubmed: 24880078 issn: 1872-7980

Lu Wang, Jing Ai, Yanyan Shen, Haotian Zhang, Xia Peng, Min Huang, Ao Zhang, Jian Ding, Meiyu Geng